Ubrogepant-话题@MedSci

#Ubrogepant#

2篇内容 | 1213人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2175203, encodeId=e13921e5203d3, content=<a href='/topic/show?id=1ffc2e613ae' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=c9b710602185' target=_blank style='color:#2F92EE;'>#偏头痛#</a></a> <a href='/topic/show?id=6f6545546c' target=_blank style='color:#2F92EE;'>#CGRP#</a> <a href='/topic/show?id=fa8718068f5' target=_blank style='color:#2F92EE;'>#Ubrogepant#</a> <a href='/topic/show?id=50a3108635b8' target=_blank style='color:#2F92EE;'>#乌布吉泮#</a>, objectTitle=Lancet：CGRP受体阻断剂Ubrogepant在前驱期使用可预防中重度偏头痛的发作, objectType=article, longId=802012, objectId=38c0802012b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231216/aa95a9296d224b22b8750189ed424974.jpg, objectUrl=/article/show_article.do?id=38c0802012b5, replyNumber=0, likeNumber=84, createdTime=2023-12-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=38c0802012b5, moduleTitle=Lancet：CGRP受体阻断剂Ubrogepant在前驱期使用可预防中重度偏头痛的发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38c0802012b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175204, encodeId=3df121e520467, content=<a href='/topic/show?id=1ffc2e613ae' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=c9b710602185' target=_blank style='color:#2F92EE;'>#偏头痛#</a></a> <a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a> <a href='/topic/show?id=943e8085574' target=_blank style='color:#2F92EE;'>#肉毒杆菌毒素#</a> <a href='/topic/show?id=6f6545546c' target=_blank style='color:#2F92EE;'>#CGRP#</a> <a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a> <a href='/topic/show?id=8d9f15481b0' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4a51106261f1' target=_blank style='color:#2F92EE;'>#rimegepant#</a></a> <a href='/topic/show?id=fa8718068f5' target=_blank style='color:#2F92EE;'>#Ubrogepant#</a>, objectTitle=偏头痛药物的市场和研发管线综述, objectType=article, longId=801980, objectId=1025801980c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231216/32921b92a05c44bb9413033ffa07f1cf.jpg, objectUrl=/article/show_article.do?id=1025801980c8, replyNumber=0, likeNumber=146, createdTime=2023-12-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=1025801980c8, moduleTitle=偏头痛药物的市场和研发管线综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1025801980c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2058220, encodeId=e8832058220be, content=<a href='/topic/show?id=fa8718068f5' target=_blank style='color:#2F92EE;'>#Ubrogepant#</a>, objectTitle=NEJM：Ubrogepant治疗偏头痛的疗效和安全性, objectType=article, longId=184215, objectId=cdd3184215d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdd3184215d1, replyNumber=0, likeNumber=64, createdTime=2020-02-16, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdd3184215d1, moduleTitle=NEJM：Ubrogepant治疗偏头痛的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdd3184215d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2058219, encodeId=4e2920582197c, content=<a href='/topic/show?id=fa8718068f5' target=_blank style='color:#2F92EE;'>#Ubrogepant#</a>, objectTitle=JAMA：Ubrogepant治疗急性偏头痛, objectType=article, longId=183321, objectId=6ea4183321ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea4183321ae, replyNumber=0, likeNumber=77, createdTime=2020-03-11, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea4183321ae, moduleTitle=JAMA：Ubrogepant治疗急性偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea4183321ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Ubrogepant

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#偏头痛# #CGRP# #Ubrogepant# #乌布吉泮#

Lancet：CGRP受体阻断剂Ubrogepant在前驱期使用可预防中重度偏头痛的发作

2023-12-16发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#偏头痛# #药物研发# #肉毒杆菌毒素# #CGRP# #Erenumab# #rimegepant# #Ubrogepant#

偏头痛药物的市场和研发管线综述

2023-12-16发表于威斯康星

luoxiaog (审核中...)

前往app查看评论内容

#Ubrogepant#

NEJM：Ubrogepant治疗偏头痛的疗效和安全性

2020-02-16

luoxiaog (审核中...)

前往app查看评论内容

#Ubrogepant#

JAMA：Ubrogepant治疗急性偏头痛

2020-03-11

科室
- - 订阅+
  - 更多科室
工具
服务